NCT04828109

Brief Summary

Postoperative recovery after head and neck surgery is complex, and often requires utilization of narcotic medications. The aim of this study is to evaluate reduction in pain and use of opioid medications through Virtual Reality (VR) and Fitbit wearable activity devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable surgery

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable surgery

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

October 25, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

October 31, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

March 28, 2021

Last Update Submit

October 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean daily opioid use

    Mean daily opioid use will be assessed converted into milligram morphine equivalents (MME).

    through study completion, an average of 10 days

Secondary Outcomes (7)

  • Pain scores

    through study completion, an average of 10 days

  • Anxiety

    Before surgery and at study completion, an average of 10 days

  • Depression

    Before surgery and at study completion, an average of 10 days

  • Sleep Quality

    Before surgery and at study completion, an average of 10 days

  • Patient experience and satisfaction

    at study completion, an average of 10 days

  • +2 more secondary outcomes

Study Arms (4)

VR and Fitbit

ACTIVE COMPARATOR

Daily VR use every 3 hours up to 30 minutes at a time and Fitbit daily step goal of 2,000 steps

Device: Virtual RealityDevice: Fitbit

VR Only

ACTIVE COMPARATOR

Daily VR only. Daily VR use every 3 hours up to 30 minutes at a time.

Device: Virtual Reality

Fitbit Only

ACTIVE COMPARATOR

Fitbit daily step goal of 2,000 steps.

Device: Fitbit

Control

NO INTERVENTION

Standard of care

Interventions

Use of any virtual reality experiences available

VR OnlyVR and Fitbit
FitbitDEVICE

Use of a Fitbit wearable activity device to track daily step goals.

Fitbit OnlyVR and Fitbit

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking
  • to 89 years of age.
  • Planned to undergo major head and neck surgery OHSU with an expected length of stay of two days or more.
  • Ability to understand goals of the study and willingness to sign a written informed consent document.

You may not qualify if:

  • Planned postoperative admission to the intensive care unit (ICU).
  • Social or psychiatric conditions that may interfere with compliance.
  • Isolation precautions.
  • Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset or wear a Fitbit device around the wrist.
  • History of seizure or epilepsy.
  • History of vertigo or persistent dizziness.
  • Limitations that impair mobility.
  • Use of a walker or wheelchair at baseline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health and Science University

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Ryan Li, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 28, 2021

First Posted

April 1, 2021

Study Start

October 25, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

October 31, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations